Waleria Healthtech’s CEO, Komal Baldwa, discusses the company’s new shatavari ingredient, aspurus, and applying the principles of Ayurveda in promoting women's health in the modern dietary supplement market.
Waleria Healthtech’s CEO, Komal Baldwa, spoke with Nutritional Outlook's editor Sebastian Krawiec at this year's SupplySide West about the company’s new shatavari ingredient, aspurus, and applying the principles of Ayurveda in promoting women's health in the modern dietary supplement market.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.